Cargando…

Integration of magnetic resonance imaging into prostate cancer nomograms

The decision whether to undergo prostate biopsy must be carefully weighed. Nomograms have widely been utilized as risk calculators to improve the identification of prostate cancer by weighing several clinical factors. The recent inclusion of multiparametric magnetic resonance imaging (mpMRI) finding...

Descripción completa

Detalles Bibliográficos
Autores principales: Brinkley, Garrett J., Fang, Andrew M., Rais-Bahrami, Soroush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109484/
https://www.ncbi.nlm.nih.gov/pubmed/35586139
http://dx.doi.org/10.1177/17562872221096386
_version_ 1784708909307527168
author Brinkley, Garrett J.
Fang, Andrew M.
Rais-Bahrami, Soroush
author_facet Brinkley, Garrett J.
Fang, Andrew M.
Rais-Bahrami, Soroush
author_sort Brinkley, Garrett J.
collection PubMed
description The decision whether to undergo prostate biopsy must be carefully weighed. Nomograms have widely been utilized as risk calculators to improve the identification of prostate cancer by weighing several clinical factors. The recent inclusion of multiparametric magnetic resonance imaging (mpMRI) findings into nomograms has drastically improved their nomogram’s accuracy at identifying clinically significant prostate cancer. Several novel nomograms have incorporated mpMRI to aid in the decision-making process in proceeding with a prostate biopsy in patients who are biopsy-naïve, have a prior negative biopsy, or are on active surveillance. Furthermore, novel nomograms have incorporated mpMRI to aid in treatment planning of definitive therapy. This literature review highlights how the inclusion of mpMRI into prostate cancer nomograms has improved upon their performance, potentially reduce unnecessary procedures, and enhance the individual risk assessment by improving confidence in clinical decision-making by both patients and their care providers.
format Online
Article
Text
id pubmed-9109484
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-91094842022-05-17 Integration of magnetic resonance imaging into prostate cancer nomograms Brinkley, Garrett J. Fang, Andrew M. Rais-Bahrami, Soroush Ther Adv Urol Current Best Practice for Prostate Biopsy: What is the evidence? The decision whether to undergo prostate biopsy must be carefully weighed. Nomograms have widely been utilized as risk calculators to improve the identification of prostate cancer by weighing several clinical factors. The recent inclusion of multiparametric magnetic resonance imaging (mpMRI) findings into nomograms has drastically improved their nomogram’s accuracy at identifying clinically significant prostate cancer. Several novel nomograms have incorporated mpMRI to aid in the decision-making process in proceeding with a prostate biopsy in patients who are biopsy-naïve, have a prior negative biopsy, or are on active surveillance. Furthermore, novel nomograms have incorporated mpMRI to aid in treatment planning of definitive therapy. This literature review highlights how the inclusion of mpMRI into prostate cancer nomograms has improved upon their performance, potentially reduce unnecessary procedures, and enhance the individual risk assessment by improving confidence in clinical decision-making by both patients and their care providers. SAGE Publications 2022-05-13 /pmc/articles/PMC9109484/ /pubmed/35586139 http://dx.doi.org/10.1177/17562872221096386 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Current Best Practice for Prostate Biopsy: What is the evidence?
Brinkley, Garrett J.
Fang, Andrew M.
Rais-Bahrami, Soroush
Integration of magnetic resonance imaging into prostate cancer nomograms
title Integration of magnetic resonance imaging into prostate cancer nomograms
title_full Integration of magnetic resonance imaging into prostate cancer nomograms
title_fullStr Integration of magnetic resonance imaging into prostate cancer nomograms
title_full_unstemmed Integration of magnetic resonance imaging into prostate cancer nomograms
title_short Integration of magnetic resonance imaging into prostate cancer nomograms
title_sort integration of magnetic resonance imaging into prostate cancer nomograms
topic Current Best Practice for Prostate Biopsy: What is the evidence?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109484/
https://www.ncbi.nlm.nih.gov/pubmed/35586139
http://dx.doi.org/10.1177/17562872221096386
work_keys_str_mv AT brinkleygarrettj integrationofmagneticresonanceimagingintoprostatecancernomograms
AT fangandrewm integrationofmagneticresonanceimagingintoprostatecancernomograms
AT raisbahramisoroush integrationofmagneticresonanceimagingintoprostatecancernomograms